Autologous Bone Marrow Stem Cells for Chronic Leg Ulcer Treatment in Sickle Cell Disease

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.

ClinicalTrials.gov Identifier: NCT02619734

Recruitment Status : Unknown

Verified November 2015 by Vitor Fortuna, Federal University of Bahia.
Recruitment status was: Enrolling by invitation

First Posted : December 2, 2015

Last Update Posted : December 2, 2015

View this study on Beta.ClinicalTrials.gov

Sponsor:

Collaborator:

Oswaldo Cruz Foundation

Information provided by (Responsible Party):

Vitor Fortuna, Federal University of Bahia

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Recruitment Status :	Unknown
Estimated Primary Completion Date :	July 2016
Estimated Study Completion Date :	August 2016

Publications:

Daltro GC, Fortuna V, de Souza ES, Salles MM, Carreira AC, Meyer R, Freire SM, Borojevic R. Efficacy of autologous stem cell-based therapy for osteonecrosis of the femoral head in sickle cell disease: a five-year follow-up study. Stem Cell Res Ther. 2015 May 29;6(1):110. doi: 10.1186/s13287-015-0105-2.

To Top